BioNexus Gene Lab Corp. (BGLC) vs Tianci International, Inc. (CIIT)
A side-by-side comparison of BioNexus Gene Lab Corp. and Tianci International, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGLC
BioNexus Gene Lab Corp.
$1.24IndustrialsDelayed quote: Oct 6, 2026, 9:56 AM EDT
CIIT
Tianci International, Inc.
$2.60IndustrialsDelayed quote: Oct 6, 2026, 10:00 AM EDT
Total return — BGLC vs CIIT
growth of $100 · dividends reinvested · last 6yBGLC -99.5% (-58.9%/yr)CIIT -97.5% (-46.1%/yr)CIIT compounded faster over this window
Log scale — wide-divergence pair
BGLC CIIT
BGLC vs CIIT: by the numbers
- •BGLC is the larger company ($3M vs $767016 market cap).
- •Both run net losses; CIIT's is the smaller (-14.74% vs -82.36% net margin).
Metrics side by side
Valuation
| Metric | BGLC | CIIT |
|---|---|---|
| P/S ratio | 0.95 | 0.05 |
| P/B ratio | 0.38 | 0.29 |
Profitability
| Metric | BGLC | CIIT |
|---|---|---|
| Gross margin | 11.64% | 8.79% |
| Operating margin | -42.54% | -29.17% |
| Net margin | -82.36% | -14.74% |
| ROE | -33.11% | -79.38% |
| ROIC | -32.71% | -75.92% |
Growth (annualized)
| Metric | BGLC | CIIT |
|---|---|---|
| Revenue CAGR (5Y) | -31.68% | N/A |
| Total return CAGR (5Y) | -61.00% | -63.68% |
Frequently asked
- How have BGLC and CIIT total returns compared?
- Over the past 5 years, BGLC delivered -61.00% and CIIT delivered -63.68% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.